Showing results (1-10 of 5,990) with videos related to
Sort By:
Pageof 599
Cancer Discovery|November 3, 2020
Hitting Gliomas When They Are Down: Exploiting IDH-Mutant Metabolic VulnerabilitiesChristopher J Pirozzi, Hai YanNature Reviews. Clinical Oncology|June 16, 2021
The implications of IDH mutations for cancer development and therapyChristopher J Pirozzi, Hai YanCancer Cell|May 18, 2013
Releasing the block: setting differentiation free with mutant IDH inhibitorsChristopher J Pirozzi, Zachary J Reitman, Hai YanCurrent Opinion in Neurology|October 18, 2011
Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic targetChangcun Guo, Christopher J Pirozzi, Giselle Y Lopez, et al.Acta Neuropathologica Communications|November 4, 2021
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonistCheng Xu, Heng Liu, Christopher J Pirozzi, et al.Molecular Cancer Research : MCR|July 12, 2019
CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMPCasey J Moure, Bill H Diplas, Lee H Chen, et al.Oncotarget|August 14, 2012
Mutant IDH1 is required for IDH1 mutated tumor cell growthGenglin Jin, Christopher J Pirozzi, Lee H Chen, et al.Oncotarget|October 22, 2013
The genetic landscape of anaplastic astrocytomaPatrick J Killela, Christopher J Pirozzi, Zachary J Reitman, et al.Methods in Molecular Biology (Clifton, N.J.)|August 16, 2005
Snapshot of the allele-specific variation in human gene expressionHai YanOncotarget|November 19, 2013
KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylationChangcun Guo, Lee H Chen, Yafen Huang, et al.Pageof 599